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1 INTRODUCTION 
Campylobacter species are the most common cause of human bacterial gastroenteritis. 
Campylobacter coli is prevalent worldwide, with most infections related to consumption of 
undercooked food and environmental exposure (WHO 2013). In most cases symptoms of 
campylobacteriosis are generally mild and the disease is self-limiting, however, it has been 
associated with a range of complications, such as Guillain-Barré syndrome (Skirrow 1977; 
Blaser et al. 1979; Allos 1997). EFSA and ECDC (2015a) reported about 56 deaths attributed 
to campylobacteriosis in 2013, resulting in a EU case-fatality rate of 0.05%, which was the 
highest observed in five years. Although C. coli contributes to a minority of Campylobacter 
infections (approximately 10%), its health burden is considerable and greater than previously 
thought (Tam et al. 2003).  
The lipooligosaccharide (LOS) is a glycolipid essential for bacterial survival, and is 
found in the outer membrane of some Gram-negative bacteria, including Campylobacter. 
LOS molecules, composed of an oligosaccharides core and a lipid A, contribute to structural 
integrity of the cell membrane, immune evasion, host cell adhesion, and molecular mimicry 
(Moran et al. 1996; Guerry and Szymanski 2008; Naito et al. 2010). It has been suggested 
that sialylation of the LOS increases invasive potential and reduces immunogenicity of C. 
jejuni (Guerry et al. 2000; Louwen et al. 2008). Furthermore, environmental and host 
physiological temperature affects C. jejuni LOS expression which may be an adaptive 
mechanism for colonization of different hosts (Semchenko et al. 2010). 
While most of glycoconjugate research is related to C. jejuni, little is known about 
LOS expression in C. coli. In C. coli 76339, a human strain, the presence of sialic acid was 
detected by chromatography analysis of the purified LOS, which corroborates genomic 
findings (Skarp-de Haan et al. 2014). The main objective of this study was to investigate 
whether different growth conditions affect LOS expression in C. coli and to explore their 
role in the host-pathogen interaction. 
In the first part of the thesis, the general endotoxin structure and the C. jejuni and C. 
coli LOSs structures are described. The variations in Campylobacter LOS expression, 
methods of LPS extraction, and TLR4 signaling pathway are explored in the second part of 
this thesis. In the final chapters, the purity of obtained LOS fractions, the accuracy of the 
purpald assay in estimating LOS concentration, and the effect of growth conditions on C. 
coli LOS expression are discussed. 
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2 LITERATURE REVIEW  
2.1 Background 
Campylobacter coli is a Gram-negative, thermo- and microaerophilic, non-spore 
forming bacterium from the Campylobacteraceae family. Morphologically C. coli is a 
curved, spiral or S-shaped rods 0.2-0.8 µm wide and 0.5-5 µm long, which move by a 
corkscrew-like motion, propelled by a flagellum at the end (or both ends) of the cell (Allos 
2001). Due to their similar morphology campylobacters were initially classified as vibrios 
(Smith and Taylor 1919). A vibrio-like bacterium was isolated by Doyle (1944) from pigs 
suffering from dysentery, he proposed it to be a causative agent of this disease and suggested 
the name, Vibrio coli (Doyle 1948). Decades later, Véron and Chatelain (1973) revised the 
taxonomy of a recently established genus Campylobacter and included V. coli as C. coli 
(Doyle) comb. nov. 
Campylobacters captured the attention of clinical microbiologists since 1950s, after 
pioneering work of Vinzent and colleagues (1947) who isolated V. fetus (now C. fetus) from 
the blood of three pregnant women hospitalized with fever of unknown origin; two of them 
were thereafter aborted. King (1957, 1962) detected a presence of “related vibrios” in blood 
samples of patients suffering of diarrhea and established the methods for laboratory 
diagnostics, biochemical testing, and culturing. The development and application of 
selective media resulted in the discovery of Campylobacter in the stools of patient 
hospitalized with diarrhea and fever (Dekeyser et al. 1972). The relationship between 
Campylobacter and the acute diarrheal disease was reaffirmed by Skirrow (1977).  
Campylobacter spp., particularly C. jejuni and C. coli, are zoonotic pathogens that 
exist as a commensal in most wild and domestic animals (Waldenström et al. 2002; Stanley 
and Jones 2003; Horrocks et al. 2009). Typical symptoms of campylobacteriosis include 
watery diarrhea, fever, abdominal cramps, inflammatory enterocolitis, nausea, and vomiting 
(Altekruse et al. 1999). However, asymptomatic Campylobacter infections have been also 
reported (Calva et al. 1988). Rarely, serious sequelae, such as Miller-Fisher syndrome, 
reactive arthritis, and irritable bowel may develop after campylobacteriosis (Allos 2001; 
WHO 2013). 
According to the European Food Safety Authority (EFSA), campylobacteriosis is the 
most frequently reported food-borne disease in EU: the number of confirmed cases in 2014 
was 236,851 which was an increase of 22,067 cases compared to 2013 (EFSA and ECDC 
2015b). Among the 52.6% of human isolates identified to species level, C. jejuni accounted 
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for 81.8% of the cases whereas C. coli was associated with 7.13% of the cases. In comparison 
to Salmonella Typhimurium, C. coli was responsible for 3.5 times more cases of indigenous 
foodborne disease and 4 times more hospitalizations reported in England and Wales in 2000 
(Tam et al. 2003). Although C. coli is recognized as an important human pathogen, its impact 
on public health is most likely underestimated. For example, Gürtler et al. (2005) revealed 
18.6% prevalence of diverse C. coli strains among patients with campylobacteriosis, which 
was higher than the respective data of the previous clinical studies conducted in Germany 
and other countries (Steinhauserova and Fojtikova 1999; Sopwith et al. 2003; Alpers et al. 
2004). Gillespie et al. (2002) noted the absence of routine species characterization of human 
isolates may hamper the systematic study of the C. coli epidemiology.   
2.2 Source attribution of C. coli infection 
Most cases of campylobacteriosis are sporadic and occur in late summer-early fall in 
developed countries (Horrocks et al. 2009), although, a winter peak of human C. coli cases 
has been also reported (Gillespie et al. 2002; Gürtler et al. 2005). Consumption of 
undercooked food and unpasteurized milk, environmental exposure, direct contact with 
animals, and travelling abroad are considered to be the most significant risk factors of 
acquiring Campylobacter infections (Studahl and Andersson 2000; Potter et al. 2003; 
Friedman et al. 2004; Stafford et al. 2007).  
Gillespie et al. (2002) proposed that C. coli might have different sources within the 
food chain and a different age distribution of infection compared to C. jejuni. Accordingly, 
the study of Doorduyn and colleagues (2010) revealed differences in campylobacteriosis risk 
factors in the Netherlands: a higher incidence of C. coli infection were found in the 45–59 
years age group and in urban regions. Additionally, consumption of game and internal organs 
of animals, swimming, and ownership of cats were identified as specific risk factors for C. 
coli (Doorduyn et al. 2010). Indeed, 42.4% occurrence of C. coli within pigs' liver samples 
obtained in UK retail has been reported previously (Kramer et al. 2000). C. coli has been 
also linked to waterborne outbreaks in Finland which implies a fecal contamination of 
groundwater wells (Hänninen et al. 2003).   
Nevertheless, poultry and ruminants were recognized as the principal source of human 
C. coli infection (Harris et al. 1986; EFSA 2010; Sheppard et al. 2010; Kittl et al. 2013; 
Roux et al. 2013). Siemer et al. (2005) confirmed contribution of poultry (chicken, duck, 
turkey, and ostrich) to C. coli infection; while Miller et al. (2006) described a prevalence of 
host-associated MLST alleles among 488 C. coli isolates of the different food animal origin 
(cattle, chickens, swine, and turkeys). In an EU-wide survey C. coli was detected in 13.1%, 
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9.5% and 87.1% of the isolates from broilers, cattle, and pigs, respectively (EFSA and ECDC 
2009). It should be noted, that despite the high (up to 99%) recovery of C. coli from swine 
fecal samples (Thakur and Gebreyes 2005; Horrocks et al. 2009), pig meat at retail is rarely 
contaminated with Campylobacter (Stern et al. 1985; EFSA and ECDC 2009).  
 2.3 Complications of campylobacteriosis  
Although uncommon, Campylobacter infection may have extraintestinal 
manifestations such as bacteremia, neonatal sepsis, meningitis, endocarditis, osteomyelitis, 
and septic shock (Allos 2001). In an 11-year surveillance study, Skirrow and colleagues 
(1993) estimated an incidence of 1.5 bacteremia cases per 1000 campylobacteriosis patients, 
and 89% of bacteremia cases were associated to C. jejuni and C. coli.  According to Louwen 
et al. (2012) neonates, elderly and immunocompromised individuals are the population at 
risk. Fernández-Cruz et al. (2010) reported about 16.4% mortality due to Campylobacter 
bacteremia, while complications appeared in 23.9% of patients. In a Finnish nationwide 
study, severe complications (Guillain-Barré syndrome and cervical spondylodiscitis) were 
found in two patients hospitalized with C. jejuni bacteremia (Feodoroff et al. 2011). 
Guillain-Barré syndrome (GBS) is the most important post-infectious sequel of 
campylobacteriosis. GBS is an autoimmune acute demyelinating polyneuropathy resulting 
in muscle weakness and neurological damage. Rees et al. (1995) reported that one third of 
the patients with severe GBS characterized by extensive axonal injury and respiratory failure 
had preceding C. jejuni infection. Molecular mimicry between GM-1 gangliosides of 
peripheral nerves and terminal structures on the lipooligosaccharide (LOS) of C. jejuni has 
been observed (Willison and Yuki 2002; Yuki et al. 2004).  
GBS induced by campylobacteriosis is widely recognized as a true case of molecular 
mimicry-mediated disease (Moran et al. 1996; Ang et al. 2004; WHO 2013). The crucial 
role of C. jejuni genes related to LOS biosynthesis and sialylation in the induction of anti-
ganglioside antibodies was elucidated (Gilbert et al. 2000; Godschalk et al. 2004). 
Bersudsky et al. (2000) claimed that LOS of C. coli isolated from the patient with GBS had 
a ganglioside mimicry. In contrast, Funakoshi et al. (2005) and van Belkum et al. (2009) 
postulated that there is no relationship between C. coli enteritis and GBS.  
2.4 History of endotoxin research 
The heat-stable toxic component of Gram-negative bacteria was discovered and 
termed “endotoxin” by Richard Pfeiffer at the end of the 19th century (Morrison 1983).  
Pfeiffer experimentally showed that lysates of heat-inactivated Vibrio cholerae are able to 
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induce shock and death in laboratory animals; he proposed that the unknown toxic substance 
is present inside the bacterium and being released only after destruction of the bacterial cell 
wall. In this way, he coined the term “endotoxin” to distinguish it from an exotoxins released 
during bacterial growth in culture (Bone 1993). Hort and Penfeld (1912) developed the first 
rabbit pyrogen test and discovered that lysates of various Gram-negative bacteria (but not 
Gram-positive) were pyrogenic despite prolonged heat treatment.  
The first endotoxin extraction method employing trichloroacetic acid was introduced 
by Boivin and Mesrobeanu (1933). Endotoxins of several Gram-negative bacteria were 
isolated and identified as carbohydrate-lipid complexes (Landsteiner and Chase 1937). 
However, extraction of relatively pure endotoxin was only feasible after the introduction of 
a novel hot phenol-water method by Westphal et al. (1952). Westphal and colleagues (1952) 
revealed the endotoxin nature of lipopolysaccharides (LPS) and their immunogenic 
properties. Soon after, the lipid A, a subunit of LPS, was identified as the actual toxic moiety 
(Westphal and Lüderitz 1954).  
After the investigation of C. fetus LPS toxicity and chemical structure by Vigdahl 
(1967), the association between lipid A and a toxic manifestations was corroborated. 
Furthermore, it was suggested that the LPS conformation was important for the immune 
response (Vigdahl 1967). Later on, artificial E. coli lipid A exhibiting identical endotoxic 
activity to its natural counterpart was synthesized (Galanos et al. 1985). In this way, the 
previous results were verified and an important toxin of Gram-negative bacteria was 
completely identified. 
2.5 General aspects of endotoxin structure 
LPS is the major component of the outer membrane of Gram-negative bacteria, 
contributing to its structural integrity. Hence, LPS is absolutely essential for bacterial 
survival. Moreover, LPS is involved in various physiological and ecological bacterial events, 
such as nutrient diffusion, membrane permeability, surface adhesion, bacteriophage 
sensitivity, and interactions with other cells, including mammalian immune cells (Nikaido 
and Vaara 1985). 
Endotoxins of Gram-negative bacteria share a common general structure. Chemically, 
LPS is an amphiphilic macromolecule, comprised of three distinct domains: a lipophilic 
moiety (lipid A), and the two hydrophilic parts – core oligosaccharide (OS) and the O-
specific polysaccharide (O-antigen) (Figure 1). Bacteria expressing the O-antigen have a 
smooth shape, thus this form of LPS is called smooth. In contrast, the rough LPS form (R-, 
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or LOS) is lacking the O-antigen (Holst and Molinaro 2009). Both forms contain lipid A and 
a core oligosaccharide that is comprised of up to 15 sugar residues (Holst 1999). 
 
Figure 1. Electron micrograph of Campylobacter coli (A) and schematic representation of enterobacterial 
LPS in the bacterial cell wall (B), LPS structure (C) and the lipid A structure (D). GlcN, D-glucosamine; Hep, 
L-glycero-D-manno-heptose; Kdo, 2-keto-3-deoxy-octulosonic acid; P, phosphate. Adapted from Ng et al. 
(1985); Beutler and Rietschel (2003) with permission from the publishers.  
Lipid A, in most cases, has a β-(1→6)-linked D-glucosamine (GlcN) disaccharide 
backbone, phosphorylated at positions 1 of the proximal a-GlcN and 4′ of the distal b-GlcN 
(Figure 1, D). Both GlcN residues are connected at positions 2 and 3 with 3-hydroxy fatty 
acids via amide and ester linkages; these fatty acids anchor the LPS into the outer leaflet of 
the outer membrane by hydrophobic interactions (Takayama et al. 1983; Silipo and Molinaro 
2011). Lipid A is the most conserved and essential for bacterial viability part of LPS which 
determines endotoxic effects of bacteria (Galloway and Raetz 1990).  
Lipid A can stimulate the innate immune system via recognition by the toll-like 
receptor TLR4 (see Chap. 2.10), sometimes causing sepsis and septic shock due to a systemic 
uncontrolled pro-inflammatory state (Takeuchi and Akira, 2010). The primary structure of 
lipid A determines its immunogenic properties. The lipid A containing two GlcN with an 
asymmetric (4 + 2) distribution of the saturated fatty acids and two phosphoryl groups 
represents the most active TLR4 agonistic structure (Rietschel et al. 1994). Any variations 
in this “canonical” lipid A structure, e.g. in number, position, length of acyl groups, 
phosphorylation pattern or tilt angle of the GlcN backbone, affect a physicochemical and 
biological behavior of the lipid A and, consequently, its endotoxin bioactivity (Seydel et al. 
2000).  
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Due to their amphiphilic nature, LPS form three-dimensional aggregates (LPS 
micelles) in aqueous environments above a critical aggregation concentration, displaying a 
thermotropic polymorphism (Seydel et al. 1989; Aurell and Wistrom 1998). Brandenburg et 
al. (1993) reported that LPS and free lipid A with a nonlamellar inverted (cubic or 
hexagonal) structure exhibited full endotoxicity, while laminar aggregates were 
endotoxically inactive.   
The core OS can be divided into two parts: one covalently linked to lipid A (inner core 
OS), and one attached to the O-antigen (outer core OS) (Figure 1, C). The structure of the 
inner core is rather conserved within a genus or family (Raetz and Whitfield 2002). At least 
one residue of 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo) and several heptoses (usually, 
the L-glycero-D-manno isomers) are present in the inner core of the OS of most Gram-
negative bacteria (Wilkinson 1996). Kdo links the inner core to the lipid A by the ketosidic 
bond (α2→6) which is prone to acid cleavage, hence, it is possible to separate the lipid A 
from LPS by mild acid treatment (Osborn 1963; Rosner et al. 1979). Kdo is an unusual sugar 
rarely found in other glycoconjugates, thus Kdo has been effectively utilized as a diagnostic 
marker for the LPS (Osborn et al. 1964; Lüderitz et al. 1966; Osborn et al. 1972; Lee and 
Tsai 1999). The inner core OS often contains a non-stoichiometric amounts of other 
substituents, such as (di)phosphate, 2-aminoethyl phosphate (PEtN), uronic acids and 4-
amino-4-deoxy-L-arabinose (L-Ara4N) (Boll et al. 1994; Silipo and Molinaro 2011). These 
substitutes along with Kdo provide a negative charge to LPS and contribute to membrane 
stability (Holst 2011). 
The outer core OS is a docking site for the O-antigen made of common hexoses, such 
as D-glucose, D-mannose, D-galactose, and N-acetylhexosamines (Wilkinson 1996). The 
outer core regions of Enterobacteriaceae LPS display structural microheterogeneity: one 
core type was identified in Salmonella, while five core types were observed in E. coli (R1–
R4 and K-12) (Jansson et al. 1981). LOS of mucosal pathogens, such as Neisseria, 
Haemophilus, Bordetella, and Campylobacter, contain a different type of outer core OS: 
substituted glycans are attached to heptose residues, while linear neutral hexoses determine 
the length of the oligosaccharide (Griffiss et al. 1988; Phillips et al. 1990; Aspinall et al. 
1993a,b,c). Furthermore, in absence of the protecting O-antigen, these LOS allow bacteria 
to evade host’s defense (e.g. phagocytosis and complement-mediated killing) by structural 
mimicry of epitopes of mammalian glycosphingolipids and incorporation of N-acetyl 
neuraminic acid (Neu5Ac) to the outer core region (Mandrell and Apicella 1993). 
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The O-antigen is the most variable component of LPS, and it is made of 
oligosaccharide repeating units (O-units) composed of several identical or different 
monosaccharides, which may be linear or branched. Variations in the O-antigen gene 
clusters cause a high diversity of O-antigens structures and compositions. Moreover, 
heterogeneity may be expanded by lateral glycosylation or O-acetylation introduced by 
prophage genes (Keenleyside and Whitfield 1999). The broad variability of O-antigens 
facilitates immune evasion and enables serological typing of different bacterial strains 
(Reeves 1995).  
The newly synthesized LPS molecules are translocated across the periplasm and 
through the outer membrane occupying 75% of its surface. The polysaccharide region is 
oriented outwards from the membrane and extends up to 10 nm from the surface (Caroff and 
Karibian 2003). The quantity of LPS is lower in rough than in smooth strains, it was 
estimated that E. coli possess ~ 2-3.5x106 LPS molecules per cell (Raetz 1986; Rietschel et 
al. 1994). As part of the bacterial outer membrane the LPS molecules are not toxic per se. 
However, free LPS released during division or lysis of bacteria evokes an immune response 
(van Amersfoort et al. 2003). 
2.6 Campylobacter LOS structure 
The detailed structure of C. jejuni lipid A was elucidated by Moran et al. (1991a). C. 
jejuni lipid A contains a biphosphorylated hybrid 2,3-diamino-2,3-dideoxy-D-
glucopyranoses (GlcN3N) and GlcN backbone (Moran et al. 1991a). Furthermore, 
heterogeneity of the lipid A polar head groups (e.g., substitution by ethanolamine phosphate) 
was observed (Figure 2). In spite of the presence of a long-chain fatty acids (16:0) in the 
lipid A, C. jejuni LPS had slightly lower biological activity compared to other enterobacterial 
endotoxins (Naess and Hofstad 1984a; Moran 1995). Moran (1997) suggested that a lower 
fluidity of Campylobacter lipid A and variations in its supramolecular structure (due to the 
length of acyl groups and/or GlcN3N substitution) may influence the lipid A activity. Later 
on, a relationship between low agonistic activity of C. jejuni and conical/concave shape of 
its lipid A has been established (Schromm et al. 2000). 
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Figure 2. Chemical structure of the C. jejuni CCUG 10936 lipid A. Numbers indicate the lengths of acyl 
chains; dashed lines represent a partial substitution due to microheterogeneity. Adapted from Moran et al. 
(1991a). 
It is well known that lipid A fine structure varies among different bacterial genera, and 
also within species of the same genus (Rietschel et al. 1994; Silipo and Molinaro 2011). 
GlcN instead of GlcN3N and a different fatty acid composition was detected in C. fetus lipid 
A (Moran et al. 1994). These findings were in accordance with previous study of Vigdahl 
(1967) who discovered the occurrence of Kdo in C. fetus LPS and estimated LD50 of its lipid 
A (5900 µg/mouse). Naess and Hofstad (1984b) found that C. coli lipid A resembled an 
enterobacterial “classical” variant: it contained the common fatty acids (tetradecanoic, 3-
hydroxytetradecanoic and hexadecanoic acids) and both glucosamine and phosphate. 
Accordingly, GlcN-GlcN disaccharide backbones were detected in the lipid A of nine C. coli 
isolates (Culebro et al. 2016).  
Naess and Hofstad (1984b) proposed that C. coli contain R-type oligosaccharide 
(LOS) composed of Kdo, L-glycero-D-manno-heptose, glucose, galactose, and 
glucosamine. Such monosaccharide composition of C. coli LOS was confirmed by Beer et 
al. (1986), additionally, 3-amino-3.6-dideoxyglucose was detected. The core OS structure 
of C. coli serotype 0:30 was solved by Aspinall et al. (1993a): notably, a phosphate 
substitutes (either as monoester or PEtN) were absent in the inner core, while the general 
disaccharide unit of L-glycero-α-D-manno-heptose (L-α-D-Hep) was expanded by the 
indirectly attached third L-α-D-Hep. Furthermore, Neu5Ac residues were absent in C. coli 
LOS, and both (R)-3-hydroxybutyryl and 3-hydroxy-2,3-dimethyl-5-oxoprolyl groups acted 
as the N-acyl substituents (Figure 3, A).  The core OS structures of a different C. jejuni 
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strains were elucidated and a molecular basis for the serotypic differences and ganglioside 
mimics was established (Aspinall et al. 1993b,c). 
     
      Figure 3. Chemical structures of the core regions of C. coli serotype O:30 (A) and C. jejuni serotypes O:1 
(R = β-D-GalNAc) and O:2 (R = H) (B). Adapted from Aspinal et al. (1993a,b,c). 
Penner et al. (1983) described the 42 thermostable serotypes of C. jejuni and 17 of C. 
coli, which were identified by a passive hemagglutination assay similarly to the LPS antigens 
of other Gram-negative bacteria. Nevertheless, Logan and Trust (1984) confirmed a low 
molecular mass (Mr) of C. jejuni and C. coli LOS and the absence of O-antigen. On the 
contrary, Mandatori and Penner (1989) reported about isolates of C. coli possessing both 
low and high Mr-LPS: O-antigens were detected by immunoblotting with homologous 
antisera. Chart et al. (1996) suggested that these heat-stable antigens were not long-chain S-
LPS, but a capsular polysaccharide (CPS). Later, Karlyshev et al. (2000) confirmed that 
assumption and demonstrated that the high Mr LPS of C. jejuni is biochemically and 
genetically unrelated to LOS and actually belong to CPS. Following studies revealed a 
complex nature and strain-dependent variations of polysaccharides produced by 
Campylobacter: e.g., C. jejuni 81116 produces a LPS-associated neutral polysaccharide B 
and a CPS-related acidic polysaccharide A (Kilcoyne et al. 2006).  
2.7 Variation of LOS 
2.7.1 Genetic basis of Campylobacter LOS diversity 
Modulation of the surface glycoconjugate expression is an important strategy for 
Campylobacter adaptation to microenvironments and survival in the host (Karlyshev et al. 
2005a). A high genetic diversity in the LOS and CPS loci was found in C. jejuni (Dorrel et 
al. 2001). These gene clusters were subsequently characterized and used to classify strains 
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into classes: 35 classes had hitherto been defined for CPS (Poly et al. 2015) and 22 for LOS 
(Parker et al. 2005; Parker et al. 2008; Richards et al. 2013). 
Structural variation of the CPS and LOS in C. jejuni is the result of multiple 
mechanisms, such as lateral gene transfer, gene inactivation by deletion or insertion of a 
base, single mutations causing the inactivation of a glycosyltransferases (e.g. 
heptosyltransferase I, sialyltransferase), and phase variation due to homopolymeric 
nucleotide runs of variable length (Parkhill et al. 2000; Gilbert et al. 2002). 
Phase variation determines a structural inherent heterogeneity of Campylobacter LOS 
and LPS of other mucosal pathogens, such as Neisseria spp., in which a single bacterial 
strain can express a repertoire of LOS molecules (van Putten 1993; Parker et al. 2008; Guerry 
and Szymanski 2008). Parkhill et al. (2000) discovered that variations in the length of poly 
GC tracts caused slipped strand mispairing of a sequences of otherwise identical clones. 
Additionally, authors concluded that phase variation was associated mostly with genes 
involved in C. jejuni LOS biosynthesis. Linton et al. (2000a) confirmed phase variation of 
β-1,3-galactosyltransferase (encoded by wlaN gene), which resulted in expressing either 
GM1 or GM2 ganglioside mimicry in the LOS of C. jejuni NCTC 11168. Guerry et al. (2002) 
reported a shift in core OS structure of C. jejuni 81-176 (from GM2 to GM3 – mimicking 
epitopes) due to phase variation of cgtA gene expression, which encodes an N-
acetylgalactosamine (GalNAc) transferase.  
While the majority of studies on phase variability were focused on C. jejuni, high-
frequency phase variation of flagellin expression in C. coli UA585 was discovered by Park 
et al. (2000). Authors suggested that a loss of flagellum due to mutations in a short poly T 
tract in the flhA gene may help bacteria to evade host immune response. Moreover, 
homopolymeric repeats have been detected in C. coli LOS and CPS gene regions (Richards 
et al. 2013). A variation in the number of L-α-D-Hep and/or PEtN residues was observed in 
C. coli isolates, however, no poly GC tracts were detected within LOS loci (Culebro et al. 
2016).  In this way, authors suggested that phenotypic variation in C. coli LOS composition 
may be determined by other factors, such as post-transcriptional regulation. 
A significant strain-dependent heterogeneity in the electrophoretic mobility and Mr of 
C. coli LOS was observed by Logan and Trust (1984). In accordance with this diversity of 
phenotypic chemotypes and similarly to C. jejuni, high gene diversity for the CPS and LOS 
loci was detected in C. coli (Lang et al. 2010). Aforementioned gene clusters have been 
characterized (Richards et al. 2013, Skarp-de Haan et al. 2014, Culebro et al. 2016): 11 C. 
coli LOS classes have been established. A diversity in LOS locus sizes (from 3 kbp to 18 
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kbp) among the Finnish C. coli isolates has been reported, implying that C. coli may have 
more, yet undiscovered, LOS classes (Culebro 2013; Culebro et al. 2016). Importantly, the 
genetic LOS classes displayed a host-specific distribution: the majority of human isolates 
pertained to LOS locus classes II, III, and IV, while swine was associated to LOS classes VI 
and X, and poultry was positively associated with class I (Culebro et al. 2016).  
2.7.2 LOS sialylation 
Sialic acid (Neu5Ac), a monosaccharide with a nine-carbon backbone, is widely 
distributed among vertebrate cells as a component of surfaces glycans, where it is employed 
in various cellular processes (e.g., cell adhesion and signaling). Some pathogenic bacteria 
can beneficially use sialic acid as a nutrient or as a protection against the host’s innate 
immune response by synthesizing it de novo or scavenging directly from the host (Severi et 
al. 2007). 
Many human pathogens, including Escherichia coli K1, Haemophilus influenzae, 
Pasteurella multocida, Neisseria spp., possess sialylated LPS. In most C. jejuni strains sialic 
acid is present as a constituent of the outer core OS (Moran et al. 1991b, 1997). Linton et al. 
(2000b) identified and characterized the multiple variants of neuB which encodes Neu5Ac 
synthetase in C. jejuni. The structure of sialyltransferase cst-II, the enzyme that transfers the 
sialic acid moiety, was elucidated by Chiu et al. (2004).  
It was suggested that LOS sialylation decreases immunoreactivity and enhances serum 
resistance and invasiveness of C. jejuni in intestinal epithelial cells (Guerry et al. 2000; 
Louwen et al. 2008). In contrast, in the study of Ellström et al. (2013) only 23% of the C. 
jejuni strains isolated from patients with bacteremia contained LOS sialylation genes. 
Furthermore, no difference in serum resistance was observed between strains expressing 
sialic acid on their LOS and asialo-LOS strains (Ellström et al. 2013). Keo et al. (2011) 
proposed that C. jejuni CPS contributes more to complement resistance, while LOS protects 
against cationic antimicrobial peptides. 
Nevertheless, certain classes of C. jejuni LOS (namely, A, B, and C) harboring 
sialyltransferase-encoding genes (cst-II, cst-III) are strongly associated with GBS, 
demonstrating that sialylation of the LOS is essential for the ganglioside mimicry (Gilbert 
et al. 2000, 2002; Godschalk et al. 2004). Two more LOS classes (R and M), possessing a 
Neu5Ac biosynthesis and transfer genes (neuBCA, cst) and thus potentially capable of 
inducing GBS, were described recently (Parker et al. 2008). Interestingly, three sialic acid 
orthologs were found not in LOS, but in the CPS cluster of C. coli H8 and 2553 (Richards 
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et al. 2013). Skarp-de Haan et al. (2014) detected sialic acid in the purified LOS of C. coli 
76339 by chromatography analysis, corroborating genomic findings (Figure 4). 
 
Figure 4. LOS locus of C. coli 76339. Black arrows indicate the conserved genes; neuBCA, the sialic acid 
biosynthesis genes; cst-V, putative sialyltransferase. Adapted from Skarp-de Haan et al. (2014). 
Sialylated LPS and CPS help bacteria to evade the immune response, however, the 
presence of Neu5Ac may not be always beneficial in diverse microenvironments inside or 
outside the host (Severi et al. 2007). It is known that some pathogens, such as Neisseria spp., 
H. influenzae and C. jejuni, employ a rapid and reversible phase variation in order to 
modulate the structure of surface glycoconjugates (van der Woude and Bäumler 2004). Van 
Putten (1993) showed that sialylation of N. gonorrhoeae LPS controls bacterial passage 
across the mucosal barrier and the evasion of the host immune response in a phase-variable 
manner.  
2.7.3 Growth conditions and phenotypic adaptation of LOS expression 
The structure, composition, and content of bacterial endotoxins are modulated by 
growth conditions such as temperature, growth phase, and nutrients availability (Wilkinson 
1996).  
Thermal regulation of the fatty acid composition of LPS was observed in various 
enterobacterial species (Salmonella spp., E. coli, Proteus mirabilis, Yersinia enterocolitica): 
low growth temperature (12-15 °C) resulted in increased incorporation of unsaturated fatty 
acids into lipid A (Rottem et al. 1978; van Alphen et al. 1979; Wilkinson 1996). Kawahara 
et al. (2002) discovered that Y. pestis grown at 27 °C possessed predominantly tetraacylated 
lipid A with significantly higher L-Ara4N content, this lipid A was a stronger inducer of 
tumor necrosis factor. Knirel at al. (2005) reaffirmed these findings and suggested that a 
production of less immunogenic LPS at mammalian temperature (37 °C) may compromise 
the rapid immune response of a host.  
Phenotypic variation of a LPS structures due to specific parameters of growth media 
may be reflected in the proportions of phosphate or PEtN groups, Kdo and heptoses, terminal 
sugars, amino acids, carbamoyl, and other non-stoichiometrical groups (Wilkinson 1996). 
Rosner et al. (1979) discovered that E. coli grown in low phosphate media possess two LPS 
fractions with a different degree of esterification in the fatty acyl groups. Tsai et al. (1983) 
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observed subtle variations in the SDS-PAGE profiles and in the galactose content of the N. 
meningitidis LPS extracted from cultures grown in different media under varied levels of 
aeration. McGee and Rest (1996) investigated LOS expression and serum resistance of N. 
gonorrhoeae strain F62 grown in different carbon sources and growth conditions. Authors 
noted that the presence of pyruvate and lactate in the growth medium significantly enhanced 
LOS sialylation, while a broth-grown bacteria expressed the highest sialyltransferase 
activity. Accordingly, pyruvate-grown N. gonorrhoeae was up to 16-fold more serum 
resistant than glucose-grown strains (McGee and Rest 1996). 
Under certain growth conditions or in absence of selective pressure some Gram-
negative bacteria may undergo irreversible smooth-to-rough (S-R) mutation. This type of 
LPS gradual shortening was used as a diagnostic marker for Coxiella burnetii, causative 
agent of Q fever (Lukáčová et al. 2007). Furthermore, it was shown, that Salmonella Anatum 
grown at lower temperature possess LPS lacking O-antigen with the higher in vitro phage-
inactivating capacity (McConnell and Wright 1979). 
C. jejuni and C. coli are thermotolerant and microaerophilic bacteria, their optimal 
growth conditions include a low oxygen tension (5% O2, 10% CO2, and 85% N2) and 
relatively high temperature (42 °C). Garénaux et al. (2008) demonstrated that the oxidative 
stress response in C. jejuni is influenced by the growth temperature in a strain-dependent 
manner. Stintzi (2003) identified 336 genes (approximately 20% of C. jejuni genome) which 
were differentially expressed at 37 °C compared to 42 °C. Among them were the genes 
encoding the LOS biosynthesis and modification enzymes like UDP-glucose 4-epimerase 
(galE), phosphoheptose isomerase (gmhA2), Kdo transferase (kdtB), acylneuraminate 
cytidylyltransferase (neuA2), Neu5Ac synthetase (neuB3), putative ADP-heptose synthase 
(waaE), and a putative glycosyltransferase (wlaE) (Stintzi 2003).  
Semchenko et al. (2010) discovered that C. jejuni strains of different origin grown at 
37 °C and 42 °C possess heterogeneous LOS fractions: e.g., C. jejuni NCTC 11168 
expressed the additional low-Mr LOS form which was different in size and structure from 
the GM1-mimicking LOS previously described by Corcoran and Moran (2007). The 
production of this low-Mr LOS was temperature-dependent, a shift from 5% at 37 °C to 35% 
at 42 °C was observed (Figure 5). Authors excluded an influence of phase variation and 
suggested that the observed LOS diversity displayed by human and chicken isolates of C. 
jejuni grown at different temperatures may be associated with a stress response or adaptive 
processes occurring during the colonization of different hosts (Semchenko et al. 2010). 
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Figure 5. Silver-stained LOS of C. jejuni strains 11168-O, 11168-GS and 520 grown at 37 °C (lanes 1, 3, 
5) and 42 °C (lanes 2, 4, 6). Adapted from Semchenko et al. (2010). 
Corcoran and Moran (2007) reported about expression of additional polysaccharide 
fractions in C. jejuni NCTC 11168 influenced by growth conditions. One fraction developed 
the mid-Mr bands on a gels stained with Alcian Blue and did not react with anti-GM1 
antibodies or cholera toxin, suggesting its attribution to capsular polysaccharides (Karlyshev 
2000; Corcoran and Moran 2007). The second, previously undescribed, non-reactive, 
polysaccharide-related component was expressed at 37°C in broth cultures only. This 
component had a high-Mr ladder-like band pattern on a silver stained gel similar to the 
neutral LPS of C. jejuni 81116 (Corcoran and Moran 2007).  
2.8 LPS extraction, purification, and quantification.  
A variety of methods have been developed for endotoxin/LPS extraction from whole 
cells (wet or dry) or cell-wall preparations from Gram-negative bacteria (Table 1). The 
phenol-water procedure of Palmer and Gerlough (1940) modified by Westphal et al. (1952, 
1965) is the most widely used LPS extraction method due to its simplicity and efficiency: in 
a cooled biphasic phenol-water mixture (45:55, v/v) proteins dissolve in the phenol phase, 
while LPS, nucleic acids, and other polysaccharides remain in the aqueous phase. 
However, several studies reported unexpected results in hot phenol-water R-LPS 
isolation – LOSs were found in an interphase and in a phenol phase (Kasai and Nowotny 
1967). Thereafter, Galanos et al. (1969) established a new LOS extraction method utilizing 
phenol-chloroform-petroleum ether mixture (PCP), which is characterized by generally 
higher yields of water-soluble R-LPS and an exclusion of S-LPS forms. Lindberg and Holme 
(1972) evaluated several methods of LPS extraction from Salmonella Typhimurium: LPS 
obtained by the hot phenol-water method from mechanically disrupted γ-irradiated bacterial 
cells was more pure than LPS from acetone-dried or formaldehyde-fixed bacteria. Authors 
also confirmed that PCP-extraction is more suitable for R-LPS strains (Lindberg and Holme 
1972). 
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Table 1. Methods of the endotoxin/LPS extraction employing the distinct treatments and agents, in 
chronological order. Adapted from Wilkinson (1996), Ridley et al. (2000). 
Treatment Reference 
0.25 N Trichloroacetic acid, 4 °C for 3 h 
5% toluene, trypsin, 37 °C for 5 days, fractionation with ethanol 
Diethylene glycol, 37 °C for 2 h, 0 °C for 2-3 d 
2.5 M solution of urea, 38 °C for 9 h 
95% phenol, saline, ethanol precipitation 
50% pyridine, 37 °C for 24 h 
Water (filtrates of suspensions), 80 °C for 1 h 
90% (w/v) phenol, 65-68 °C, 20-30 min. 
0.15 M NaCl, diethyl ether (1:2, by vol.), 12 °C 
5% cetyltrimethylammonium bromide, 5 °C for 10 min; pyridine-formic 
acid (76:49), 30 min 
Dimethyl sulphoxide (DMSO), 60 °C for 4 h 
89% aqueous phenol-chloroform-petroleum (2:5:8, by vol.), 5-20 °C for few 
min  
0.15 M NaCI-butanol (1:1), 0-4 °C for 15 min.; 0.5 M EDTA (pH 8.0-8.5), 
37 °C for 15 min 
90% (w/v) phenol, 70°C, 15 min, pretreatment with lysozyme (4 °C for 16 
h), DNase, RNase  
0.1 M EDTA, 2% SDS, 10 mM Tris, 37 °C, overnight. Ethanol precipitation. 
2% SDS, 4% 2-mercaptoethanol, 10% glycerol, 1 M Tris (pH 6.8), 100°C 
for 10 min. 
Hot phenol-water method, gel filtration on a 2.5x100-cm Sephadex®G-75 
column 
MgCl2-Triton X-100 solution, 100°C for 10 min; 0.2 M EDTA (pH 8.0), 
37 °C for 60 min 
Lyophilization of biomass. Water, 100 °C for 15 min. Proteinase K 
treatment. 
96% (v/v) ethanol, methanol extraction 
30 mM sodium triphosphate pentabasic, 1 h, supercritical carbon dioxide, 
10 g/min, 90 °C 
Boivin et al. (1933) 
Raistrick and Topley (1934) 
Morgan (1937) 
Walker (1940) 
Palmer and Gerlough (1940) 
Goebel et al. (1945) 
Roberts (1949) 
Westphal et al. (1952) 
Ribi et al. (1961) 
Nowotny et al. (1963) 
 
Adams (1967) 
Galanos et al. (1969) 
 
Leive and Morrison (1972) 
 
Johnson and Perry (1976) 
 
Darveau and Hancock (1983) 
Hitchcock and Brown (1983) 
 
Wu et al. (1987) 
 
Uchida and Mizushima 
(1987) 
Eidhin and Mouton (1993) 
 
Nurminen and Vaara (1996) 
Rybka et al. (2008) 
 
Nowotny et al. (1963) concluded that a different species of Enterobacteriaceae require 
different LPS isolation procedures. Johnson and Perry (1976) improved the yield of the 
conventional phenol-water procedure (1.7-12.4 - fold) by preceding disruption of cells by 
grinding with glass beads or pretreating with lysozyme in presence of EDTA. 
Aforementioned method was adapted for LOS and further improved by Wu et al. (1987) by 
applying a gel filtration resulted in better yield (30-108% higher) and purity. Darveau and 
Hancock (1983) developed a LPS isolation technique employing a solubilization step with 
sodium dodecyl sulfate (SDS), which was effective in extracting high yields of both smooth 
and rough LPS.  
Nevertheless, undesirable compounds such as proteins, RNA, and polysaccharides 
often contaminate LPS preparations obtained by the different isolation procedures. 
Essentially pure LPS requires the additional purification steps: ultracentrifugation, ethanol 
precipitation, enzymatic treatment with DNase, RNase, proteinase K, dialysis and/or gel 
filtration (Leive and Morrison 1972; Darveau and Hancock 1983; Wu et al. 1987). Muck et 
al. (1999) compared the traditional LPS purification methods, such as enzymatic digestion 
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and ultracentrifugation, and the separation by hydrophobic interaction chromatography 
(HIC): the latter technique produced LPS of superior purity with a minimal loss of product. 
Logan and Trust (1984) applied the hot-phenol method for LOS extraction from C. 
jejuni and C. coli: resulted LOS yield was ~ 0.8% of the Campylobacter dry weight, and the 
lyophilized LOS was considerably less soluble than reference E. coli LPS.  Perez-Perez and 
Blaser (1985) found that the LPS extraction procedure of Darveau and Hancock (1983) was 
more suitable for serum resistant C. fetus strains, while the phenol-water method had greater 
yields in serum-sensitive C. jejuni and C. fetus strains; overall LPS yields ranged from 0.9 
to 8.3%. Blake and Russel (1993) emphasized the role of technical factors in the isolation of 
C. jejuni LOS by comparing the results of the PCP method of Galanos et al. (1969) and the 
rapid isolation-staining method of Al-Hendy et al. (1991). 
Determination of LPS in the extracted fractions is traditionally based on the detection 
of the lipid A, heptose and/or Kdo (Vigdahl 1967; Osborn et al. 1972; Darveau and Hancock 
1983; Perez-Perez and Blaser 1985; Wu et al. 1987). Kdo can be identified by gas-liquid 
chromatography, mass spectrometry, or by a colorimetric assay with thiobarbituric acid 
(Waravdekar and Saslaw 1959; Weissbach and Hurwitz 1959). However, the thiobarbituric 
acid assay is not applicable for certain bacteria, including V. cholera, H. influenza, B. 
pertussis, C. coli and C. jejuni, which contain only one Kdo at the C-4 or C-5 position, 
impeding the periodic acid digestion (Brade et. 1983; Carof et al. 1987; Lodowska et al. 
2013). In order to overcome this obstacle, Lee and Tsai (1999) developed a new method of 
bacterial LPS measurement – the purpald assay, in which the unsubstituted terminal vicinal 
glycol (UTVG) groups of the Kdo and heptoses are oxidized by periodate, producing 
formaldehyde measurable spectrophotometrically via reaction with the purpald reagent.  
Another commonly used method for LPS quantification is the turbidimetric Limulus 
amoebocyte lysate (LAL) assay which is 3 to 300 times more sensitive than the rabbit 
pyrogen test (Wachtel and Tsuji 1977). Gu et al. (1995) applied quantitative densitometry 
of silver-stained SDS-PAGE gels for measuring the levels of released and cell-bound LOSs 
from H. influenzae strains. Authors concluded that this method was 100-fold more sensitive 
than the Kdo assay but less sensitive than LAL assay.  
2.9 Innate immunity and Toll-like receptors.  
The human immune system is responsible for the recognition and subsequent 
elimination of different pathogenic entities via acute inflammation. The innate immune 
system response is triggered by microbial invasion or by the presence of endotoxins. The 
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main cell-effectors are phagocytes: dendritic cells (DCs), macrophages, and neutrophils. 
However, non-specialized cells such as epithelial and endothelial cells may also contribute 
to innate immunity (Takeuchi and Akira 2010). The innate immune response is important 
not only for pathogen clearance, but also for the activation of acquired immunity employing 
T- and B-lymphocytes (Medzhitov and Janeway 1997a). 
The concept of immune recognition was proposed by Janeway (1989): he coined the 
term “pattern recognition receptors” (PRRs), describing the receptors on antigen-presenting 
cells (APC) which sense a microbial presence and induce a second signaling. PRRs are 
capable to detect the conserved structures of microorganisms, i.e. pathogen-associated 
molecular patterns (PAMPs). The recognizing of PAMPs by PRRs upregulates the 
transcription of genes responsible for inflammatory response, affecting the expression of 
various pro-inflammatory mediators, e.g. cytokines, interferons, chemokines (Medzhitov 
and Janeway 1997b, 2002). These mediators cause a complex cascade of events, such as 
exudation of fluids, increased vessel permeability, and attraction of leukocytes, resulting in 
phagocytosis and clearance of a microbes (Heumann and Roger 2002). 
The family of Toll-like receptors (TLRs) is one of four PRRs families found in the 
innate immune system of mammals. TLRs are responsible for microbial presence detection 
outside the cell and in intracellular endosomes and lysosomes (Akira et al. 2006). The term 
“Toll” originally referred to a protein with a single transmembrane domain determining a 
dorsal-ventral orientation of the Drosophila embryo (Anderson et al. 1985). Lemaitre et al. 
(1996) demonstrated that Toll was crucial for the response of Drosophila to fungal infection. 
Later, a homologue of the Drosophila Toll receptor was discovered in mammals (Medzhitov 
et al. 1997).  
TLRs consist of an extracellular domain with leucine-rich repeats and a cytosolic 
domain containing a TOLL/interleukin-1 receptor (TIR). To date 10 human TLRs have been 
identified, different TLRs recognize and specifically bind the different PAMPs and self-
components (Table 2). TLR-specific ligands represent, for example, microbial lipids such as 
LPS, and nucleic acids from bacteria and viruses. Upon binding, PAMPs provoke the 
dimerization of two domains of TLRs, which in turn activates a different signaling pathways 
depending on the TIR domain-containing adaptor molecules recruited to receptors (O’Neill 
and Bowie 2007). In general, TLR signaling is organized via two distinct pathways 
employing MyD88 and TRIF adaptor molecules. 
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Table 2. Human TLRs and their ligands. Adapted from Pandey et al. (2015). 
Receptor Main ligands Associated pathogens 
TLR1 
TLR2 
TLR3 
TLR4 
 
TLR5 
TLR6 
TLR7 
TLR8 
TLR9 
TLR10 
Triacylated lipoproteins 
Lipoproteins, peptidoglycan, LPS (some species) 
dsRNA 
LPS (major species), respiratory syncytial virus (RSV) 
fusion protein 
Flagellin 
Diacylated lipoproteins 
ssRNA 
ssRNA 
CpG motifs (DNA) 
Unknown 
Bacteria, spirochetes, mycoplasma 
Bacteria, viruses, parasites, self 
Viruses 
Gram-negative bacteria, RSV 
 
Bacteria with flagella 
Bacteria, viruses 
Viruses, bacteria, self 
Viruses 
Bacteria 
- 
 
2.10 LPS recognition and TLR4 activation.  
LPS acts as the endotoxin because it binds the CD14/TLR4/MD2 receptor complex in 
APCs, such as macrophages, monocytes, dendritic cells and B cells, which activates a host 
defense through secretion of reactive oxygen, nitric oxide, pro-inflammatory cytokines, and 
eicosanoids (Figure 6, A). Cytokines, particularly tumor-necrosis factor (TNF), interleukin 
(IL)-1 and IL-6, are prime mediators of the endotoxin activity, they act directly or via 
hormonal or paracrine system (Tracey and Cerami 1992). It should be noted, that the 
uncontrolled, massive release of kinins and eicosanoids is dangerous, as it may contribute to 
a pathological process and distort the balance between pro- and anti-inflammatory pathways 
causing hypotension, disseminated intravascular coagulation, septic shock, and death 
(Hodgson 2006). 
 
Figure 6. LPS-induced innate immune response (A), LPS recognition and a core pathway of TLR4 
signaling (B). TNF, tumor-necrosis factor; NO, nitric oxide; PAF, platelet-activating factor; LT, lymphotoxin; 
SAPK, stress-activated protein kinase; IRAK, interleukin-1 (IL-1) receptor-associated kinase; TRAF6, TNF 
receptor-associated factor 6. Adapted from Beutler and Rietschel (2003); Heumann and Roger (2002) with a 
permission from the publisher. 
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Chow et al. (1999) demonstrated that TLR4 is engaged in LPS signaling and following 
activation of a transcription factor NF-κB. The important role of TLR4 was confirmed in 
TLR4-knockout mice which were unresponsive to LPS (Poltorak et al. 1998). Besides TLR4, 
recognition of LPS requires a participation of other molecules (Figure 6, B): LPS-binding 
protein (LBP), plasma membrane glycoprotein – the cluster differentiation antigen 14 
(CD14), and an extracellular protein called myeloid differentiation factor 2, MD2 (Tobias et 
al. 1986; Wright et al. 1990; Shimazu et al. 1999).   
LBP is a 60-kD glycoprotein synthesized by hepatocytes in the liver, LBP expression 
increases in response to endotoxin (Tobias et al. 1986; Schumann et al. 1990). The 
importance of LBP is determined by the amphiphilic nature of LPS molecules: in aqueous 
solution they form micelles poorly recognizable by monocytes and macrophages (Wright et 
al. 1989). LBP binds the LPS monomers through the lipid A moiety (Mathison et al. 1992; 
Taylor et al. 1995) and transfers them to CD14, which is present at the surface of the 
myelomonocytic cells (mCD14) or circulates in the serum in soluble form (sCD14) (Gegner 
et al. 1995; Yu and Wright 1996).  
CD14 acts as a functional receptor for LPS, it drastically increases the sensitivity of 
cells to lipid A, allowing to bind picomolar concentrations of endotoxin (Lee et al. 1992). 
Haziot et al. (1996) discovered that CD14-deficient mice, in spite of expression of the other 
proteins necessary for LPS recognition, were resistant to endotoxic shock. In contrast, Huber 
et al. (2006) stated that R-LPS (LOS) can activate cells independently from the CD14. 
Structurally CD14 is a dimer, which contains a hydrophobic “pocket” binding the acyl chains 
of the lipid A (Kim et al. 2005). CD14 lacks an endoplasmic domain, thus the transmembrane 
proteins, TLR4 and MD2, are needed for a further signal transduction (Akira 2003).  
CD14 transfers the LPS molecules to the TLR4-MD2 receptor complex; MD2 is 
attached to the TLR4 ectodomain and it is crucial for LPS signaling (Shimazu et al. 1999; 
Gangloff and Gay 2004). The number, position and length of the lipid A fatty acids affect 
MD2 conformation, hence, influencing TLR4 activation (Seydel et al. 2000; Hajjar et al. 
2002). For example, a lipid A with five acyl chains is 100-fold less active than the 
“canonical” variant, while Eritoran, a synthetic analogue of lipid A with four acyl chains, 
completely lack agonistic activity and acts as TLR4 antagonist (Teghanemt et al. 2005). The 
crystallographic studies on TLR4, MD2, and LPS interaction revealed that two TLR4-MD2-
LPS complexes form a symmetrical m-shaped homodimer (Park et al. 2009).  
Stimulation with LPS initiates TLR4 signaling through recruitment of the adapter 
molecule MyD88 and the IL-1 receptor-associated kinase (IRAK) (Muzio et al. 1998). 
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MyD88, myeloid differentiation factor 88, is the Toll-like cytoplasmic adapter, which binds 
to TLR4 via TIR domain adaptor protein (TIRAP) (Kagan and Medzhitov 2006). Following 
interaction of MyD88 with IRAK, a serine/threonine kinase with an N-terminal death 
domain (Takeuchi and Akira 2010), activates the NF-κB via TRAF6 (Figure 6, B). Apart 
from MyD88-dependent signaling, TLR4 triggers a TRIF-dependent pathway resulting in 
the activation of IRF3 transcription factor (Yamamoto et al. 2003). Nevertheless, the MyD88 
gene was shown to be critical for TLR signaling: MyD88-deficient mice were unresponsive 
to LPS (Adachi et al. 1998; Kawai et al. 1999). 
2.11 Innate immune response to Campylobacter  
In the intestine, Campylobacter adhere to and invade the intestinal epithelial cells, 
inducing a pro-inflammatory response in the host tissues (Janssen et al. 2008). In order to 
evade the innate immunity system, bacteria employ different strategies. Watson and Galan 
(2005) discovered that C. jejuni flagellin poorly stimulates TLR5 and pro-inflammatory 
cytokine production. Furthermore, it has been shown that DNA from C. jejuni weakly 
activates TLR9 due to low GC content (Dalpke et al. 2006).  
Nonetheless, innate immunity is crucial for host defense. The essential role of TLR 
pathways was determined in MyD88-deficient mice, which were prone to Campylobacter 
infection and colonization (Watson et al. 2007). Previous studies showed that C. jejuni 
infection of human monocytic cells initiates NF-κB translocation (Mellits et al. 2002; Jones 
et al. 2003); NF-κB-dependent mechanism of C. jejuni clearance was proven in knockout 
mice (Fox et al. 2004). A prominent role of the intracellular PRR, NOD1, in innate response 
to C. jejuni was elucidated by Zilbauer et al. (2007), authors suggested that activation of 
both TLRs and NOD-like receptors by different PAMPs can modulate invasion and 
epithelial innate responses.  
C. jejuni CPS can stimulate IL-6 secretion from intestinal epithelial cells through 
TLR2 in a MyD88-independent manner (Friis et al. 2009). High levels of NF-κB activation 
by lysed bacteria via human TLR1/2/6 and TLR4 and chicken TLR2t2/16 and TLR4 were 
reported by de Zoete et al. (2010). Interestingly, viable C. coli activated TLR4 moderately, 
while no response was detected for viable C. jejuni strains (de Zoete et al. 2010). Hu et al. 
(2006) observed in vitro maturation of dendritic cells (DCs) infected with viable and dead 
Campylobacter cells, followed by the activation of multiple cytokines of both innate and 
specific immune systems. Notably, purified LOS from C. jejuni strain 81-176 used in the 
study induced high levels of TNF, gamma interferon, and interleukins, implying a key role 
of LOS in the stimulation of cytokines in DCs (Hu et al. 2006).  
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Variations in Campylobacter LOS structure and composition influence TLR4 
activation. According to van Mourik et al. (2010) inactivation of the genes encoding 
synthesis of GlcN3N precursor enhances the TLR4-MD2-mediated NF-κB response and 
susceptibility to antimicrobial peptides (AMPs). In contrast, removal of PEtN from C. jejuni 
lipid A resulted in attenuated TLR4-MD2 activation and decreased resistance to mammalian 
and avian AMPs (Cullen et al. 2013). Kuijf et al. (2010) reported that sialylation of C. jejuni 
LOS increases TLR4 and DCs activation, as well as B cell proliferation. Recently, a 
cumulative effect of C. jejuni LOS modifications, namely, sialylation, phosphorylation and 
abundance of ester linkages, on TNF induction and TLR4 signaling was observed 
(Stephenson et al. 2013). 
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EXPERIMENTAL RESEARCH 
3 AIMS OF THE STUDY 
The main aim of this thesis was to investigate whether different growth conditions (i.e. 
growth medium and temperature) affect C. coli LOS expression and its immunogenicity. 
The objectives were: 
1. To compare electrophoretic patterns of LOS extracted from Campylobacter coli 
grown under different conditions. 
2. To evaluate the effect of different growth conditions on human Toll-like receptor 4 
(TLR4) response using the HEK-Blue™ hTLR4 cells. 
3. To highlight possible method-based biases in studying Campylobacter LOS-host 
interaction. 
 
4 MATERIALS AND METHODS  
4.1 Bacterial strains and growth conditions 
Eight Campylobacter coli strains were selected for the present study from the 
laboratory collection (Table 3).  Pure cultures were obtained from -70 °C stock and routinely 
grown at 37 ºC under microaerobic conditions (85% N2, 10% CO2, 5% H2) on NBA agar 
comprised of the nutrient broth № 2 (CM0067, Oxoid Ltd. Basingstoke, UK) and 1.5% agar, 
supplemented with 5% (v/v) of defibrinated horse blood, unless stated otherwise.  
Table 3. Description of C. coli strains selected for a study. 
Strain 
number 
Strain Source Year Country LOS 
class 
Reference 
38 DSM-24199  Pig     -    Denmark VIII Campynet collection 
45 FB6470 Human 1996    Finland X  Kärenlampi et al. (2007) 
51 76339 Human 2006    Finland IX Skarp-de Haan et al. (2014) 
73 2946 Poultry 1999    Finland II Kärenlampi et al. (2007) 
138 E107.3 Pig 2009    Finland X Olkkola et al. (2010) 
Juntunen et al. (2010, 2011) 
Olkkola et al. (2010)  
Juntunen et al. (2010, 2011) 
151 E163.2 Pig 2009    Finland II 
137 E90.1 Pig 2009 Finland II 
177 A35.1 Pig 2007 Finland IV 
Effect of growth conditions on LOS expression was assessed by cultivating C. coli 
strains at different temperatures (37, 39, and 42 °C, corresponding to the human, swine, and 
avian host body temperature, respectively) for 24 hours in presence/absence of defibrinated 
horse blood (NBA/NA agar), 5% (v/v), and presence/absence of N-acetylneuraminic acid – 
Neu5Ac (Sigma-Aldrich, St. Louis, MA, USA), 50 µm/ml. C. coli strains were grown under 
different conditions three times independently (three biological replicates).  
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4.2 LOS extraction 
During the present investigation C. coli LOSs were extracted by different methods 
which are described below. 
4.2.1 Fast crude LOS extraction 
NA/NBA plates with C. coli strains grown at 37 ºC were washed with 1 ml Dulbecco’s 
Phosphate Buffered Saline (DPBS, Sigma-Aldrich Corporation, St. Louis, MA, USA). 
Bacterial suspensions were adjusted by OD600 measurement to 0.5 and treated proteinase K 
(0.6 µg/µl) (Thermo Fisher Scientific, Waltham, MA, USA) at 55°C for 1 hour. Samples 
were inactivated by boiling for 10 min. Then, LOS samples were run in 15% acrylamide gel 
and visualized by silver staining.  
4.2.2 Mini-phenol-water LOS extraction 
C. coli biomass from NA and NBA plates was collected by washing with endotoxin-
free DPBS. Bacterial suspensions were centrifuged at 5000 g for 5 min, pellets were washed 
3 times with DPBS and finally resuspended in 1.5 ml DPBS, and stored at -70 °C until further 
use. 
Afterwards, 750 µl aliquots of bacterial mass samples were centrifuged at 5000 g for 
5 min, supernatants were discarded, and pellets were resuspended in 750 µl PCR water. 
LOSs were extracted using mini-phenol-water method of Prendergast et al. (2001), with 
some modifications. Briefly, 750 µl pre-heated (60 °C) 90% (v/v) aqueous phenol was added 
to each sample, tubes were vortexed for 1 min and incubated at 65 °C for 15 min, with 
vortexing for 30 sec at 2 min intervals. Tubes then were cooled on ice and centrifuged at 
15000 g for 3 min. The upper clear aqueous phase containing the LOS was transferred to a 
new tube. Then, LOS was re-extracted from the phenol phase by adding 300 µl of sterile 
water. 
Residual phenol from the LOS phase was removed by layering 0.5 ml diethyl ether, 
vortexing, centrifuging (15000 g, 3 min, 4 °C) and discarding the ether phase 3 times. 
Remaining diethyl ether was removed from LOS samples by evaporation for 1 hour. 
Extracted LOS were stored at -20 °C until further use. 
4.2.3 Hot phenol-water LOS extraction 
C. coli biomass was obtained as previously described. The pellets were resuspended 
in 10 ml buffer containing 10 mM Tris-HCL and 5 mM EDTA (pH 7.4), and digested with 
lysozyme (1 mg/ml), RNase A (50 µg/ml), DNase I (25 µg/ml), and proteinase K (100 
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µg/ml). Bacterial lysates were then subjected to LOS extraction employing the hot phenol-
water method (Westphal et al. 1952), essentially as described above. After diethyl ether 
extraction the LOS samples of two biological repetitions were mixed with two volumes of 
cold absolute ethanol with 0.375 M sodium acetate pH 5.4 and incubated overnight at -20 
°C. Upon ethanol precipitation samples were centrifuged at 16000 g for 40 min, pellets were 
washed with 70% cold ethanol and centrifuged again under the same conditions. Dried 
pellets were resuspended in 1 ml sterile endotoxin-free water and were stored at 4 °C until 
further use. 
4.3 LOS lyophilization 
LOS samples extracted by the hot phenol-water method were lyophilized using 
DryWinner 3 freeze-dryer (Heto Holten, Denmark) following the manufacturer’s 
instructions (-53 °C, ~0.1 hPa, overnight). 
4.4 Agarose gel electrophoresis 
In order to detect possible DNA/RNA contamination LOS samples were subjected to 
electrophoresis in a 1.5% (w/v) SeaKem® LE Agarose gel (Lonza, Basel, Switzerland) 
stained with 1 mg/ml of ethidium bromide, in 1 X TAE buffer for one hour at 110 V, gels 
were viewed under UV light and photographed by the AlphaImager IS-2200 (Alpha Innotech 
Corp., San Leandro, CA, USA). Molecular weight marker GeneRuler 1 kb DNA Ladder 
(Thermo Fisher Scientific Inc., Waltham, MA, USA) was used as a reference. 
4.5 LOS concentration measurement 
Quantification of LOS was performed by the purpald assay (Lee and Tsai 1999). In 
brief, 10 µl of 36 mM NaIO4 was added to 10 µl of LOS samples and incubated for 25 min 
at room temperature. Then, 10 µl of 136 mM purpald reagent (Sigma-Aldrich, St. Louis, 
MA, USA) was added. After incubation for 20 min at room temperature, 10 µl of 64 mM 
NaIO4 was added and samples were further incubated for 20 min. Finally, samples were 
measured at 550 nm with NanoDrop-1000 Spectrophotometer (Thermo Fisher Scientific 
Inc., Waltham, MA, USA), and LPS of E. coli 0111:B4 (Sigma-Aldrich, St. Louis, MA, 
USA) was used as a standard.  
4.6 SDS-PAGE of LOS 
The concentration of the LOS samples was adjusted to 0.3 µg/µl in 20 µl prior to 
electrophoresis. Then, 20 µl of Laemmli sample buffer (Bio-Rad Lab. Inc., Hercules, CA, 
USA) with 4% 2-mercaptoethanol was added (1:1), and 13 µl of mixture was subjected to 
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15% (v/v) sodium dodecyl suphate-polyacrylamide gel electrophoresis (SDS-PAGE), which 
was conducted at 20 mA for 2 h. LPS of E. coli 0111:B4 (0.3 µg/µl) was used as a control. 
Gels were silver stained (Tsai and Frasch 1982), and images were captured and analyzed 
using the GS-800™ calibrated densitometer and PDQuest 2-D analysis software, version 7.3 
(Bio-Rad Lab. Inc., Hercules, CA, USA).  
4.7 Detection of sialic acid 
NBA plates with C. coli and C. jejuni 81-176 (positive control) biomass were washed 
with DPBS. Then, 200 µl aliquots of each samples were adjusted by OD600 measurement to 
0.5, and proteinase K (0.6 µg/µl) was added. Afterwards, tubes were incubated at 55°C for 
1 hour, followed by boiling for 10 min. Aliquots (20 µl) were transferred to two 1.5 ml 
Eppendorf tubes containing either 5 µl of sterile endotoxin-free water (negative control) or 
neuraminidase from Clostridium perfringens (Sigma-Aldrich, St. Louis, MA, USA). Upon 
overnight incubation at 37 ºC samples were loaded to SDS-PAGE. 
4.8 Cell cultures 
HEK-Blue™ hTLR4 cells and HEK-Blue™ Null2 cells (InvivoGen, San Diego, CA, 
USA) were maintained and subcultured in DMEM (Life Technology, Carlsbad, CA, USA) 
according to manufacturer’s instructions. The growth media were renewed as necessary; 
cells were passaged when a 70-80% confluency was reached.  
Infection of HEK-Blue™ hTLR4 and HEK-Blue™ Null2 cells with LOS was done in 
triplicate (3 technical repetitions). Plates with 25000 cells/well were prepared and incubated 
for 18 hours at 37 °C, 5% CO2. Upon incubation, cells were infected with LOS samples at a 
final concentration of 1 ng/ml and incubated for 18 hours again. LPS of E. coli 0111:B4 
(0.0625 µg/µl) was used as positive control. 
NF-κB-induced activity of secreted embryonic alkaline phosphatase (SEAP) was 
assessed using the QUANTI-Blue™ colorimetric assay (InvivoGen, San Diego, CA, USA), 
in accordance with the manufacturer’s instructions. Absorbance at 620 nm was read by 
Multiskan™ FC microplate photometer (Thermo Fisher Scientific, Waltham, MA, USA). 
4.9 Statistical analysis 
Statistical analysis was performed using GraphPad Prism version 6 for Windows (San 
Diego, CA, USA). One-way ANOVA with Tukey-Kramer post-test (cut-off 0.05) was 
applied for a group comparison, for pairwise comparison paired and unpaired two-tailed t-
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tests with Welch correction were used. Error bars in the graphs in figures represent either 
Standard Error of the Mean (SEM), or Standard Deviation (SD). 
5 RESULTS 
5.1 LOS mobility patterns 
LOSs from C. coli strains 38, 45, 51, 73, 138, and 151 grown under different conditions 
(37 °C, 39 °C, 42 °C / NA and NBA), and C. jejuni strain 81-176 grown at 37 °C on NBA 
were run on SDS-PAGE. Figure 7 shows the LOSs extracted with mini-phenol-water 
method, Figure 8 demonstrates the LOSs of six C. coli strains extracted with hot-phenol 
method, and Figure 9 – the pattern from crude extracts. All tested LOS samples extracted 
with both methods resolved as a one band of low Mr (~4 kDa). The observed differences in 
electrophoretic mobility of the LOS samples were strain-dependent. A different intensity of 
the bands or their absence (Figure 7, A, lanes 8-11) on the SDS-PAGE gels was unexpected, 
as all LOS samples were standardized prior to electrophoresis. 
 
Figure 7. Silver stained SDS-PAGE gels of miniphenol-water-extracted LOSs from C. coli strains grown 
under various conditions. Lanes 1, 14, 16, 23, 25, and 31 contain the purified LPS from E. coli 0111:B4 as a 
positive control. Lanes 2-7 contain LOS samples of C. coli 38 grown on NA agar (2, 4, 6) and NBA agar (3, 5, 
7) at 37°C (2, 3), 39°C (4, 5) and 42 °C (6, 7). Same pattern of LOS samples applies to C. coli 45 (lanes 8-13), 
C. coli 51 (15, 17-21) and C. coli 73 (22, 24, 26-29). Lanes 30 and 32 contain LOS of C. jejuni 81-176. LOS 
samples were standardized to 0.3 µg/µl by the purpald assay. 
Furthermore, SDS-PAGE analysis revealed that LOSs of C. coli strains 45 and 138 
were absent in two biological repetitions (Figure 8, lanes 6-9, 21-24, and 37-44). Moreover, 
24 LOS samples of 3rd biological repetition adjusted to 0.3 µg/µl by the purpald assay were 
not detected on SDS-PAGE gels (Appendix I). 
   35 
 
 
 
 
Figure 8. Silver stained SDS-PAGE gels of the phenol-water-extracted LOS from C. coli biomass grown 
under different conditions, 1st rep. samples (A, B) and 2nd rep. (C, D). Strains and growth conditions tested are 
indicated above the bands. Lanes 1, 14, 16 27, 31, 32, 46, and 59 contain the purified LPS from E. coli 0111:B4 
as a positive control. Lanes 15, 30, 45, and 60 are empty, negative control. LOS samples were precipitated in 
ethanol prior to freeze-drying, except the samples in lanes 34, 37, 38, 39, 43, 44, and 56 which were freeze-
dried only. LOS concentration was measured by the purpald assay. Samples were standardized to 0.3 µg/µl 
prior to electrophoresis. 
The crude-extracted LOS preparations of six C. coli strains grown on NBA and NA 
media at 37 °C were subjected to SDS-PAGE (Figure 9). As it was observed previously in 
this study, Mr of isolated LOS samples varied between the strains tested, but not between 
the growth conditions (Figure 9, A). 
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Figure 9. Silver staining of crude LOS samples of C. coli strains 38, 45, 51, 73, 138, and 151 (digested cell 
lysates). Strains were grown on NA and NBA at 37 °C, obtained biomass was standardized by OD600 
measurement and treated with proteinase K. Lanes 1, 8, 15, 22, and 27 contain the purified LPS from E. coli 
0111:B4 (0.3 µg/µl). Lanes 2, 3, 5, 7, 9, 12, 18, and 21 contain the crude LOS of one repetition. 
5.2 Standardization by weight 
Due to the observed discrepancies between the estimated and actual LOS quantities, 
electrophoretic analysis of LOS banding patterns was repeated. The LOS samples of 3rd 
biological repetition were re-lyophilized, weighed and resuspended in endotoxin-free water 
to a concentration of 2-4 mg/ml. However, detection of LOS in SDS-PAGE was still not 
possible in all the cases (Figure 10, A). No significant differences in electrophoretic mobility 
of the studied LOS samples were detected (Figure 10, B). 
Accuracy of the both methods of LOS concentration measurement applied in the 
present study, weighing and the purpald assay, was evaluated. The lyophilized LOS samples 
of C. coli strains 73 and 45 (3rd rep., 37 °C, NA) were adjusted to the concentrations used in 
the purpald assay for a standard curve construction (2-0.125 µg/µl). These LOS samples and 
the purified LPS from E. coli 0111:B4 were loaded to SDS-PAGE and analyzed by the 
purpald assay (Figure 11). While a dilution pattern of C. coli 73 LOS was clearly 
distinguishable on the SDS-PAGE gel, the resuspended freeze-dried LOS preparations of C. 
coli strain 45 did not yield a bands (Figure 11, A). Moreover, at least 60-fold overestimation 
of a LOS concentration by the purpald assay was observed. Both C. coli 73 and 45 LOS at 
concentrations of 2, 1 and 0.5 µg/µl caused a saturation of the reagents used in the purpald 
assay, while LOS samples of 0.25 µg/µl and 0.125 µg/µl were beyond the range of the 
standard curve (Figure 11, B). 
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Figure 10. Silver stained SDS-PAGE gels of the phenol-extracted and re-lyophilized C. coli LOS samples, 
3rd rep. (A), and LOS samples of C. coli strains 73 and 151 grown in presence of Neu5Ac at 37 °C (B). All 
lyophilized LOS samples were weighed and adjusted to 2 µg/µl prior to electrophoresis. The strains and 
conditions tested are indicated above the bands. Lanes 1, 14, 16, and 23 contain the purified LPS from E. coli 
0111:B4 (0.3 µg/µl) as a positive control. 
 
 
Figure 11. Silver stained SDS-PAGE gel of C. coli strains 45 and 73 LOS (3rd rep.), freeze-dried, weighed 
and diluted (A); the purpald assay of the same LOS samples and LPS from E. coli 0111:B4, latter was used for 
a standard curve (B). Numbers above the bands indicate the LOS concentration, µg/µl.  
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5.3 Neuraminidase treatment 
The crude-extracted LOS samples of C. coli strains 51, 137 and 177 were examined 
for the presence of sialic acid, and C. jejuni strain 81-176 was used as a positive control. 
These three C. coli strains were selected since they showed the presence of a 
glycosyltransferse GT-42 family homologs (Culebro et al. 2016). Cleavage of the sialic acid 
moiety by neuraminidase resulted in a shift in the control LOS band only (Figure 12, lane 
13). In this way, it can be suggested, that C. coli strains 51, 137 and 177 do not possess 
sialylated LOS (Figure 12, lanes 2, 3, 5, 6, 8, and 9). 
 
Figure 12. Silver staining of C. coli 51, 137, 177, and C. jejuni 81-176 crude LOS samples (digested cell 
lysates). Strains were grown on NBA at 37 °C, obtained biomass was standardized by OD600 measurement and 
treated with proteinase K. The LOS samples treated with neuromidase from C. perfringens are denoted as “N” 
(lanes 3, 6, 10, and 13), “b” - LOSs isolated from strains grown in liquid culture (lanes 4, 7, 10). Lanes 1 and 
11 contain the purified LPS from E. coli 0111:B4 (0.3 µg/µl). 
 
5.4 TLR4 activation 
5.4.1 Effect of LOS concentration 
C. coli LOS samples isolated by the hot phenol-water method were free from DNA 
contamination (Appendix II). HEK-293 cells stably transfected with human TLR4-MD2-
CD14 (HEK-Blue™ hTLR4) and parental HEK-Blue™ Null2 cells were stimulated with 1 
ng/ml of the LOSs of six C. coli strains grown under different conditions. The NF-κB 
induction in HEK-Blue™ Null2 cells treated with C. coli LOS was not different from 
untreated cells (OD620, 0.053±0.001). Unexpectedly, a majority of the tested LOS samples 
poorly activated a TLR4 response (Figure 13). Observed differences in levels of NF-κB 
activation among LOSs of two biological repetitions were not statistically different (p > 
0.05). Considerable variations in TLR4 response triggered by the LOS samples of the same 
C. coli strains, as well as between biological repetitions reflected incorrect estimation of 
LOS concentration. In this way, it was not possible to evaluate the effect of the growth 
conditions on immunogenicity of the LOS samples standardized by the purpald assay. 
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Figure 13. Human TLR4 activation by C. coli LOS (1 ng/ml): samples of the 1st biological repetition (A) 
and 2nd biological repetition (B). Data represent average of three technical replicates. TLR4 activation was 
assessed colorimetrically using a SEAP reporter gene placed under the control of an NF-κB-inducible 
promoter. LPS from E. coli 0111:B4 was used as the positive control. Error bars show ± SEM. Numbers under 
X-axis indicate the strain number. 
5.4.2 TLR4 stimulation with crude LOS 
The crude-extracted LOS samples of six C. coli strains induced a high TLR4 response 
(Figure 14, B).  Importantly, HEK-Blue™ Null2 cells were not triggered, which indicated 
an absence of signaling by TLR4-unspecific NF-κB-agonists (Figure 14, A). The effect of 
different growth medium on LOS immunogenicity was assessed only for C. coli strain 73, 
as LOS samples of this strain only were present in 3 independent biological replicates. It can 
be suggested that a growth medium did not affect LOS agonistic activity of C. coli strain 73, 
p > 0.05 (Figure 15). 
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Figure 14. HEK-Blue™ Null2 cells (A) and TLR4 activation (B) by the crude-extracted C. coli LOS, 
average data of three technical repetitions. The strains are indicated below. Error bars show ± SEM. Bacteria 
were grown at 37°C and standardized to appr. 4×108 cells by OD600 prior to LOS extraction. Note, that only 
LOS samples of C. coli 73 represent 3 independent biological replicates for both conditions. 
 
 
Figure 15. Effect of a growth medium on TLR4 activation by the crude-extracted LOS of C. coli 73. Error 
bars show ± SD. Data passed normality test, correlation coefficient r = 0.7, one-tailed p = 0.01. 
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6 DISCUSSION 
The LPS is an indispensable component of outer membrane of Gram-negative bacteria, 
contributing to its structural integrity. The LPS of the established food-borne pathogens, C. 
jejuni and C. coli lacks the O-antigen and therefore is often referred to as LOS. A number of 
studies emphasized the role of Campylobacter LOS in GBS development, as well as in 
biofilm formation, resistance to complement and AMPs, intraepithelial survival and host 
colonization (Moran et al. 1996; Guerry 2000; Allos 2001; Naito et al. 2010). Various 
genetic mechanisms determine a hyper variability of Campylobacter cell surface 
glycoconjugates, and differential gene expression at different growth conditions also 
contributes to a phenotypic variation of LOS structures (Dorrel et al. 2001; Semchenko et 
al. 2010). In the present work the effect of different growth conditions on C. coli LOS 
expression was assessed. However, evaluation of TLR4 agonistic activity was hampered by 
the applied LOS isolation and quantitation methods which may reflect a common 
methodological issue.  
Due to vast structural heterogeneity of bacterial endotoxins a dozens of extraction 
methods have been devised in order to conform with the variable physical properties of LPS. 
Thus, there is no universal “golden standard” for LPS isolation.  In practice, a choice of a 
particular extraction technique depends on experimental aims, LPS type (rough or smooth), 
available materials and equipment, among others. However, it is well-known that the 
different methods of LPS extraction yield products of distinct quality and quantity (Nowotny 
et al. 1963; Fukushi et al. 1964; Blake and Russel 1993; Delahooke et al. 1995; Ridley et al. 
2000). The proposed methods based on a mild treatment (heat alone, chelating agents) rely 
on week association of LPS with the outer membrane and thus they are not always effective 
and have not been widely applied (Wilkinson 1996).  
The fast crude LPS extraction method employed in the present study utilized 
proteinase K, which decreases protein content in whole-cell lysates containing LOS and 
other glycans. The LOS samples extracted by the mini-phenol-water method of Prendergast 
et al. (2001) were directly analyzed by SDS-PAGE. The quality of visualized LOS bands of 
the both extraction methods was in accordance with data from the original publications 
(Hitchcock and Brown 1983; Prendergast et al. 2001). For example, as it was observed 
before in Salmonella LPS, the staining patterns of the whole-cell lysates varied between the 
strains, most probably reflecting the biochemical composition of the chemotypes. 
Visualization of LOSs extracted by the mini-phenol-water method revealed a significant 
difference in the intensity of LOS bands on silver-stained gels, which was initially attributed 
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to technical mistakes. However, a following TLR4 activation assays revealed a more 
complex nature of this problem. Nevertheless, it can be concluded that the crude LPS/LOS 
extraction and the mini-phenol-water method are simple and rapid methods suitable for LOS 
visualization by silver staining.  
The hot phenol-water method of Westphal et al. (1952) is the widely used extraction 
procedure which is characterized by a high LPS yield but also by higher amounts of protein 
and/or nucleic acids contamination (de Castro et al. 2010). To enhance LOS yield and purity, 
biomass of the C. coli strains grown under the different conditions was enzymatically 
digested (with lysozyme, RNase A, DNase I and proteinase K) and then subjected to hot 
phenol-water extraction. Isolated LOS fractions were precipitated in cold absolute ethanol 
applying a modified method of Darveau and Hancock (1983) or lyophilized; subsequent 
agarose gel electrophoresis of purified LOS samples revealed a negligible contamination 
with nucleic acids. 
Despite undertaken measures, overall yield of hot-phenol extracted LOS was rather 
low in this study. It was shown previously, that the overnight treatment of R-LPSs of 
Salmonella spp. and E. coli K-12 with 70% or absolute ethanol containing MgCl2 at 4 °C is 
sufficient for LOS precipitation (Kato et al. 1990). However, upon ethanol precipitation and 
centrifugation, a LOS pellet was not visually detected. Poor yield or an absence of the hot-
phenol-extracted LOS have been reported before (Kasai and Nowotny 1967; Brade and 
Galanos 1982; Perez-Perez and Blaser 1985; Uchida and Mizushima 1987; Moran et al. 
1992). LOS fraction of high yield and purity was extracted in a number of studies by the 
PCP method employing an aqueous phenol-chloroform-light petroleum mixture (Galanos et 
al. 1969; Lindberg and Holme 1972; Moran et al. 1991b).  
Nonetheless, both PCP and hot-phenol methods selectively separate LPS based on its 
solubility in the organic solvent(s), which is a major drawback, as solubility varies between 
different LPS forms. Indeed, the limitations in the extraction methods sometimes may affect 
an investigation: Blake and Russel (1993) reported about non-detectable C. jejuni LPS 
isolated by the combined PCP-proteinase K method. Accordingly, it was suggested that 
certain LPS/LOS extraction methods are more suitable for certain bacterial species 
(Nowotny et al. 1963) or even strains (Perez-Perez and Blaser 1985; Ridley et al. 2000). It 
can be speculated that some amount of LOS in this study was retained in the phenol phase 
and lost during hot-phenol extraction. 
An effect on the different growth conditions on LOS expression in the tested C. coli 
strains was assessed by the SDS-PAGE analysis. As SDS-PAGE separates the LPS fractions, 
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this method is widely employed to study LPS heterogeneity; in the combination with a silver 
staining it provides a good selectivity and sensitivity (Tsai and Frasch 1982). The single 
bands at the bottom of a gel is a typical representation of LOS molecules, which due to a 
low molecular mass migrate faster than LPS. In contrast, the LPS from E. coli 0111:B4 used 
in this study, produced the polydisperse, so-called ladder-like, banding pattern due to the 
presence of molecules with a different number of repeating units in the O-antigen. The fastest 
moving band represent a complete core of LPS; the second fastest band - the core plus one 
repeating unit; and so forth (Hitchcock and Brown 1983). Importantly, the molecular weight 
of an LPS and its components cannot be estimated applying standard weight markers for 
proteins (Russell and Johnson 1975), thus, it is common to estimate Mr by comparing the 
relative mobility of the unknown LPS band on SDS-PAGE gel with the corresponding unit 
of the LPS with the published structure, such as Salmonella Typhimurium or E. coli LPSs 
(Wilkinson 1996). Nevertheless, the chemical compositions of the LOSs from nine C. coli 
isolates have been proposed and the molecular weights of their components are known 
(Culebro et al. 2016). The Mr of the C. coli LOSs tested in the present work were estimated 
based on the aforementioned findings; LOSs were approximately 4 kDa. 
Semchenko et al. (2010) investigated an influence of different growth conditions on 
C. jejuni LOS expression: silver-stained gels revealed the unique mobility patterns of LOSs 
of different strains and the temperature-dependent production of two LOS forms. In the 
present work all tested LOSs obtained from the C. coli strains grown under different 
conditions resolved as a single band, with a unique, strain-dependent values of the 
electrophoretic mobility. The latter fact reflects a structural diversity between and within the 
LOS classes. Accordingly, the similar phenotypic diversity of the phenol-extracted (Logan 
and Trust 1984) and crude (Blaser et al. 1986) C. coli LOS has been reported previously. As 
the concentration of the LPS positively correlates with the intensity of the bands (Tsai 1986), 
observed variations in intensity of the studied C. coli LOS samples reflected the improper 
standardization of the LOS concentration by the purpald assay and lyophilization/dilution. 
However, for the assessment of the molecular weight of LOS and its possible structural 
changes caused by a growth condition, normalization of the quantity of the LOS molecules 
in the studied samples is not crucial. It was demonstrated before that a loss of one heptose 
unit resulted in the different electrophoretic mobility of the studied R-LPS, furthermore, 
analogous strain-to-strain differences in the mobility were observed in the LPS samples 
extracted by the different methods (Hitchcock and Brown 1983; Sugiyama et al. 1990; 
Semchenko et al. 2010). Strain-dependent mobility of LOSs was also observed in the present 
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study. In contrast, analysis of LOS mobility patterns revealed that different growth 
conditions do not affect phenotypic LOS expression in the tested C. coli strains. 
The concentrations of all phenol-extracted and lyophilized LOS samples in the present 
study were measured by the purpald assay. Dilutions of a commercial preparation of LPS 
from E. coli 0111:B4 were made for a standard curve construction. It should be pointed out, 
that according to the published structures of inner cores, C. coli LOS and E. coli LPS possess 
similar number of the unsubstituted terminal vicinal glycol (UTVG) groups: 4 in E. coli 
strain 0111:B4 (2 at Kdo + 2 at heptoses) and 3-4 in C. coli (Jansson et al. 1981; Raetz 1990; 
Aspinall 1993a; Culebro et al. 2016). Thus, theoretically, the concentrations of these 
LPS/LOS determined by the purpald assay should be comparable to each other. However, 
the limitations of the purpald assay were emphasized by its inventors, Lee and Tsai (1999): 
the actual number of UTVG groups in the sample and the predicted number of Kdo+heptose 
units are not essentially the same, as LPS/LOS preparations are structurally heterogeneous, 
while the number of L-α-D-Hep and degree of sialylation may also vary. For example, Beer 
et al. (1986) detected 3-fold higher amount of Kdo and heptose in C. jejuni LOS than Logan 
and Trust (1984) before. 
 Notably, a significant overestimation of LOS quantity by the purpald assay was 
observed in the present work. The concentration of the extracted LOS samples which were 
precipitated in cold ethanol was within a range of the standard curve, 0.125-2 µg/µl. In 
contrast, the LOS samples obtained by the mini-water-phenol method and the freeze-dried 
LOS samples from hot-phenol extraction required a dilution, 1:50 and 1:1000, respectively. 
Furthermore, upon standardization by the purpald assay, twenty-four LOS samples 
(lyophilized and then diluted) of the six C. coli strains and several ethanol-precipitated LOS 
samples did not evoke TLR4 response and, accordingly, were not detected on the silver-
stained SDS-PAGE gels. Taking into account the high sensitivity of silver staining (limit of 
detection – 5 ng of R-LPS), an absence of LOS bands on gels disproves the fact that prior to 
electrophoresis C. coli LOS samples were normalized to 0.3 µg/µl (6 µg per well). Apart 
from excessive dilution, such phenomenon can be explained as unsuccessful extraction with 
hot phenol.  
Importantly, the amount of E. coli 0111:B4 LPS (0.3 µg/µl) used in the purpald assay 
and in SDS-PAGE analysis yielded intense bands on gel and triggered a considerable TLR4 
response. In this way, aforementioned overestimation of LOS quantity observed in this study 
was caused most probably by a certain contamination interfering with the measurement. It 
can be suggested that the ethanol precipitation applied to some extracted samples selectively 
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separated the LOS fraction (although with a probable loss of endotoxin), reducing false-
positive quantification. Lee and Tsai (1999) noted that the samples analyzed by the purpald 
assay should not contain ethylene glycol, linear monosaccharides, Tris buffer or glycerol, 
since NaIO4 will react with UTVG groups present in these molecules, producing 
formaldehyde and thus contributing to the measured absorbance values. 
Even though it can be claimed that the LOS samples obtained in this work where free 
from the aforementioned impurities, the contamination with a capsular polysaccharide (CPS) 
residues cannot be excluded. It has been demonstrated that stationary phase cells of C. jejuni 
grown on solid media had increased CPS production (Corcoran and Moran 2007). 
Previously, the purpald assay was adapted for quantification of bacterial CPS since it 
contains glycol groups (including UTVG), e.g. in ribitol, galactose, arabinitol, glycerol, and 
sialic acid moieties (Lee and Frasch 2001). Michael et al. (2002) solved the structure of CPS 
of C. jejuni 11168 which included β-D-Rib (ribose), β-D-GalNAc, glucuronic acid and D-
glycero-α-L-gluco-heptopyranose. The ability to integrate various complex heptoses in C. 
jejuni CPS was demonstrated (Karlyshev et al. 2005b). Interestingly, a similar water-soluble 
antigenic polysaccharide of high Mr has been found in phenol-water extracts of C. coli 
serotype 0:30 in a study of Aspinall et al. (1993d). This polysaccharide possessed an unusual, 
teichoic acid-like structure comprised of a poly-ribitol phosphate and 6-deoxy-talo-heptose 
(Aspinall et al. 1993d). In fact, eight CPS classes have been identified in C. coli by genomic 
analysis (Richards et al. 2013). Two putative CPS biosynthesis proteins and the 
sialyltransferase associated with the CPS locus (cst-I) were found in C. coli 76339 (Skarp-
de Haan et al. 2014), the strain that was used in this study.  
Unfortunately, the hot phenol-water method, unlike another commonly used extraction 
methods, preferentially extracts the LPS and capsular antigens. The CPS has been found in 
the aqueous phase together with endotoxin fraction (Lindberg and Holme 1972). Karlyshev 
et al. (2005b) and Michael et al. (2002) isolated the CPS fraction by the hot water-phenol 
method: the aqueous phase was lyophilized, dissolved and subjected to ultracentrifugation 
which yielded a pellet containing LOS and supernatant containing CPS. However, it was 
reported that the mixtures of LPS/LOS and CPS is difficult to purify: separation of LPS and 
CPS was not achieved by repeated ultracentrifugation (de Castro et al. 2010). Moran et al. 
(1991b) purified the LOS of C. jejuni by centrifugation at 105,000 g (4 °C, 4 h) and gel 
chromatography in order to eliminate impurities (CPS, oligosaccharides, free sialic acid) 
from the preparations. Repeated ultracentrifugation prior to the purpald assay was applied to 
purify C. jejuni LOS in the study of van Mourik et al. (2010). Such treatment was not used 
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in the present study, thus, it can be hypothesized that inaccurate estimation of LOS 
concentration by the purpald assay was due to contamination of the extracted C. coli LOS 
samples with CPS or sialic acid residues possessing UTVG groups. In summary, it can be 
concluded that a correct and reliable LPS/LOS quantification using the purpald assay 
requires a high degree of purity of the tested samples and the standards. 
Because the purpald assay was not suitable for quantification of the actual amount of 
LOS in the preparations obtained in this study, an attempt was made to adjust LOS 
concentration according to the weights of lyophilized LOS samples. It should be noted that 
lyophilization of the extracted endotoxin fractions (regardless of the isolation procedure 
used) is the most common method for a final or temporary LPS/LOS recovery. In a number 
of studies, the weight of freeze-dried LPS was measured using a high-precision balance. 
Weighing/dilution and subsequent SDS-PAGE as a control measure were employed for the 
standardization of Campylobacter LOS by Kuijf et al. (2010) and Stephenson et al. (2013). 
In this study, the LOS samples of the six C. coli strains were re-lyophilized: each samples 
yielded a white powder/foam which was weighed and resuspended in endotoxin-free water. 
However, following SDS-PAGE and silver staining revealed an absence of LOS-specific 
bands on gel in most of aforementioned samples. Therefore, it was not possible to use 
weighing and dilution as a method of standardization of a LOS concentration. Presumably, 
the lyophilized preparations contained both LOS and an undetermined contaminant(s). 
Moreover, different environmental conditions (humidity) and different ability of LOS 
structures to absorb water could also contribute to the observed discrepancies. These data 
suggest that standardization of LOS concentration by weight may lead to incorrect results. 
An accuracy of the LOS standardization by weight and by the purpald assay was 
evaluated using the phenol-extracted LOS samples of C. coli strains 45 and 73: LOS extracts 
of only one strain yielded bands in accordance with a dilution and weight used.  In contrast, 
the concentrations of all LOS samples estimated by the purpald assay were beyond the range 
of the standard curve (60-fold higher absorbance and complete saturation). This observation 
further supports a hypothesis of incorrect estimation of LOS amount by the both methods. 
Proper quantification and a purity control are crucial for an investigation of biological 
activity of endotoxins (Tirsoaga et al. 2007). The importance of LPS re-purification, 
particularly, of the elimination of a protein contamination, was shown before in a TNF 
stimulation studies (Manthey and Vogel 1994). A removal of lipoprotein contaminants from 
the commercial R-LPS preparations resulted in the diminished TLR2 activation, which 
implied that this receptor is not responsible for a LPS signaling in most species (Hirschfeld 
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et al. 2000). Accordingly, an influence of the extraction methods on a biological potency of 
endotoxins has been reported, indicating an insufficient LPS purification in many studies 
(Morrison 1983; Tirsoaga et al. 2007). Noteworthy, according to the Caroff and Karibian 
(2003) the impurities, such as, lipoproteins, nucleic acids and phospholipids, were also found 
in the commercial LPSs. 
It can be stated that the phenol-extracted LOS samples obtained in the current work 
were essentially free from DNA, RNA and protein contamination. In a study of Delahooke 
et al. (1995) protein contamination was found in all LPS preparations extracted by the 
different methods, notably, the extremely low levels of proteins were detected in phenol-
extracted LPS samples; following proteinase K treatment completely eliminated the 
presence of proteins. The human TLR4 (hTLR4) response was evaluated in this study using 
the HEK-Blue™ hTLR4 cells which express the hTLR4, the MD2/CD14 co-receptor genes 
and a secreted embryonic alkaline phosphatase (SEAP) reporter gene: the stimulation with 
LOS activates NF-κB and induces the production of SEAP. As it was mentioned before, not 
all phenol-extracted LOS samples activated the hTLR4 in this work, furthermore, it was not 
possible to assess an impact of the growth conditions on NF-κB induction due to 
unsuccessful normalization of LOS concentration. This explains the controversial data 
obtained after the stimulation of the hTLR4-expressing cells with the phenol-extracted 
LOSs.  
 In this way, an improper standardization of LOS concentration was a major limitation 
in this study which hindered the evaluation of a TLR4 response. As LPS/LOS is only 
bacterial ligand of hTLR4, possible contaminants should not affect the assay. However, 
hTLR4 reporter cells used in this study express the endogenous level of TLR3, TLR5 and 
NOD1. In order to detect possible influence of the non-specific ligands, HEK-Blue™ Null2 
cells which do not express hTLR4 were used as a control. No activation of HEK-Blue™ 
Null2 cells was seen in this work upon stimulation with the crude and phenol-extracted LOS 
samples, which implies an absence of signaling through TLR3, TLR5, and NOD1 by RNA, 
flagellin, and peptidoglycan, respectively. Hence, a stimulation of the HEK-Blue™ reporter 
cells with the crude LOS preparations in this study was methodologically appropriate. 
However, as a composition of all LOS samples was by no means certain, the usage of other 
reporter systems, e.g., macrophages or mononuclear monocytes, would be impossible. 
Accordingly, Delahooke et al. (1995) proposed that the different methods of LPS extraction 
and contamination with CPS were responsible for the unexpected levels of TNF induction 
observed in their study. The interaction of the Campylobacter CPS with the host innate 
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immune system is poorly studied, C. jejuni CPS was shown to reduce cytokine production 
in dendritic cells (Rose et al. 2012), to activate TLR2 (Friis et al. 2009) and to modulate 
TLR4 response (Maue et al. 2013), however, latter is uncertain due to often contamination 
(Phongsisay et al. 2015).  Nevertheless, it can be concluded, that the elimination of CPS and 
other impurities is essential for studies on biological activity of Campylobacter LOS. 
In order to evaluate an effect of the growth conditions on TLR4 activation by C. coli 
LOS, a different approach, unbiased by the purpald assay and weighing, was adopted. 
Bacterial suspensions were standardized by OD600 measurement prior to the fast crude LOS 
extraction. Obtained whole-cell lysates were analyzed by SDS-PAGE and then used in TLR4 
activation assay: notably, all samples produced the prominent bands on a gel and exhibited 
high agonistic activity. Subsequent statistical analysis revealed that crude LOS extracts 
obtained from C. coli strain 73 grown on different media had the similar levels of NF-κB 
activation. This finding corroborates SDS-PAGE analysis of the same crude LOS samples, 
as well as phenol-extracted LOSs.  
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7 CONCLUSIONS 
In conclusion, different growth conditions did not affect LOS mobility patterns of the 
tested C. coli strains which implies no differences in LOS composition. In contrast, strain-
dependent LOS size variation was detected. The overestimation of LOS quantity by the 
purpald assay observed in this study was caused most probably by the considerable 
contamination of the LOS samples with capsule polysaccharide (CPS) fraction. Thus, further 
studies on occurrence of CPS in C. coli are needed. Additionally, it can be suggested that 
correct standardization of LOS concentration by the purpald assay and by weighing would 
require essentially pure LOS samples. Notably, crude LPS extraction was suitable for LOS 
visualization by silver staining and for immune response evaluation using TLR4-expressing 
cells. Overall, proper research on biological activity of endotoxins requires a non-biased LPS 
quantitation and correct standardization of concentration, while the determined composition 
of endotoxins and absence of impurities may be crucial for non-specific immunological 
assays. 
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Appendix I 
 
 
 
Figure 16. TLR4 activation (A) and silver stained SDS-PAGE gels (B) of the hot phenol-water-extracted 
LOS from C. coli biomass grown under different conditions, 3rd repetition samples. Samples were not 
precipitated in ethanol. Lanes 1, 14, 26, and 28 contain the purified LPS from E. coli 0111:B4 as a positive 
control. Lanes 2-5 contain samples of C. coli 38, C. coli 45 (lanes 6-9), C. coli 51 (25-27, 29), C. coli 73 (17-
20), C. coli 138 (lanes 10-13), C. coli 151 (21-24). Lanes 15 and 30 - negative control. Concentration of LOSs 
was standardized to 0.3 µg/µl. 
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Appendix II  
 
 
 
Figure 17. Agarose gel electrophoresis of the LOSs extracted by hot phenol-water method from six C. coli 
strains grown under different conditions. Lanes 3-26 contain samples of C. coli LOSs of 2nd biological 
repetition, lanes 32-55 – of the 3rd, lanes 60-84 – of the 1st. Lanes 27, 56, and 85 contain the LPS from E. coli 
0111:B4. Lanes 1, 29, 30, 58, and 87 - negative control. Lanes 2, 28, 31, 57, 59, and 86 contain the molecular 
weight marker GeneRuler 1 kb DNA Ladder. 
 
 
 
 
